A PI3K p110α-selective inhibitor enhances the efficacy of anti-HER2/neu antibody therapy against breast cancer in mice by Jae-Hyeog Choi, Ki Hyang Kim, Kug-Hwan Roh, Hana Jung, Anbok Lee, Ji-Young Lee, Joo Yeon Song, Seung Jae Park, Ilhwan Kim, Won-Sik Lee, Su-Kil Seo, Il-Whan Choi, Yang-Xin Fu, Sung Su Yea, SaeGwang Park

Get full text